More on AGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (2.7 Score)
- Holders
- Dividends (1.5% Yield)
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- M&A (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

AGN Cash Flow Statement

Click line-items for a historical chart and %
Net earnings 1.53B
Depreciation and amortization
Amortization of original issue discount and debt issuance costs 2.8M
Amortization of net realized gain on interest rate swap -15M
Deferred income tax benefit
(Gain) loss on disposal and impairment of assets 29.8M
Unrealized loss (gain) on derivative instruments -37.2M
Expense of share-based compensation plans 159.7M
Intangible asset impairment
Expense from changes in fair value of contingent consideration
Restructuring charges
Gain on investments, net 3.1M
Trade receivables -115.7M
Inventories -43.8M
Other current assets
Other non-current assets
Accounts payable 1.9M
Accrued expenses 115.9M
Income taxes -124M
Other liabilities
Net cash provided by operating activities 1.93B
Purchases of short-term investments -1.27B
Acquisitions, net of cash acquired -67.5M
Additions to property, plant and equipment -243.9M
Additions to capitalized software -19M
Contractual purchase price adjustment to prior acquisition
Proceeds from maturities of short-term investments
Proceeds from sale of investments
Proceeds from sale of property, plant and equipment 500K
Net cash provided by (used in) investing activities 182.7M
Repayments of convertible borrowings
Dividends to stockholders -59.6M
Payments to acquire treasury stock -839.2M
Payments of contingent consideration -10.2M
Net borrowings (repayments) of notes payable 16.5M
Sale of stock to employees 521M
Excess tax benefits from share-based compensation 167.5M
Net cash used in financing activities -204M
Effect of exchange rate changes on cash and equivalents -41.2M
Net (decrease) increase in cash and equivalents 1.87B
Cash and equivalents at beginning of period 3.05B
Cash and equivalents at end of period 4.91B
Interest (net of amount capitalized) 83.4M
Income taxes, net of refunds 487.8M

Entities mentioned with AGN

View All Entities